age float64 18 102 | sex stringclasses 2
values | hospdead int64 0 1 | slos int64 3 343 | dzgroup stringclasses 8
values | dzclass stringclasses 4
values | num.co int64 0 9 | edu float64 0 31 ⌀ | income stringclasses 4
values | scoma float64 0 100 ⌀ | charges float64 1.17k 1.44M ⌀ | totcst float64 0 633k ⌀ | totmcst float64 -102.72 711k ⌀ | avtisst float64 1 83 ⌀ | race stringclasses 5
values | sps float64 0.2 99.2 ⌀ | aps float64 0 143 ⌀ | surv2m float64 0 0.97 ⌀ | surv6m float64 0 0.95 ⌀ | hday int64 1 148 | diabetes int64 0 1 | dementia int64 0 1 | ca stringclasses 3
values | prg2m float64 0 1 ⌀ | prg6m float64 0 1 ⌀ | dnr stringclasses 3
values | dnrday float64 -88 285 ⌀ | meanbp float64 0 195 ⌀ | wblc float64 0 200 ⌀ | hrt float64 0 300 ⌀ | resp float64 0 90 ⌀ | temp float64 31.7 41.7 ⌀ | pafi float64 12 890 ⌀ | alb float64 0.4 29 ⌀ | bili float64 0.1 63 ⌀ | crea float64 0.1 21.5 ⌀ | sod float64 110 181 ⌀ | ph float64 6.83 7.77 ⌀ | glucose float64 0 1.09k ⌀ | bun float64 1 300 ⌀ | urine float64 0 9k ⌀ | adlp float64 0 7 ⌀ | adls float64 0 7 ⌀ | sfdm2 stringclasses 5
values | adlsc float64 0 7.07 | event_times int64 3 2.03k | event_indicators int64 0 1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71.461 | male | 0 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 13,818 | 9,869.6172 | 8,757.28906 | 14.5 | white | 22.796875 | 25 | 0.802979 | 0.736938 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 10 | 73 | 8.699219 | 60 | 24 | 36.29688 | 128.5625 | 4.399414 | 1.799805 | 1.199951 | 139 | 7.469727 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 | 1,655 | 0 |
70.15997 | male | 1 | 3 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 55 | 3,284 | 2,367.4102 | 2,257.75 | 16 | white | 18.898438 | 26 | 0.525879 | 0.326965 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 113 | 10.298828 | 109 | 26 | 38.29688 | 414.8125 | null | null | 1.099854 | 147 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.446777 | 3 | 1 |
83.33496 | male | 0 | 200 | Coma | Coma | 2 | 17 | $11-$25k | 26 | 344,708 | 266,838.25 | 247,714 | 33 | white | 29.796875 | 43 | 0.079987 | 0.044998 | 12 | 0 | 0 | yes | null | null | dnr after sadm | 103 | 103 | 31.796875 | 118 | 38 | 39.19531 | 143.3125 | null | null | 1.399902 | 144 | 7.429688 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 226 | 1 |
65.23499 | male | 0 | 24 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 14,680 | 11,844.125 | 10,716.4297 | 9 | white | 19.398438 | 41 | 0.869995 | 0.784912 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 82 | 16.597656 | 126 | 26 | 36.09375 | 196 | 4.899414 | 0.5 | 0.899902 | 134 | 7.439453 | null | null | null | 3 | 4 | <2 mo. follow-up | 4 | 26 | 1 |
68.74695 | male | 0 | 17 | Coma | Coma | 1 | 6 | under $11k | 55 | 13,519 | 10,571.8984 | 8,644.44531 | 13.333328 | white | 18.5 | 35 | 0.555908 | 0.487 | 1 | 1 | 0 | no | 0.25 | 0.2 | dnr after sadm | 1 | 131 | 12.798828 | 71 | 24 | 39 | null | 5.099609 | 0.599976 | 2 | 136 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 | 19 | 1 |
67.67694 | female | 0 | 91 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 259,766 | 208,491.375 | 194,043.875 | 22.75 | white | 28.699219 | 36 | 0.613892 | 0.507935 | 52 | 1 | 0 | no | 0.3 | 0.05 | dnr after sadm | 38 | 63 | 10.5 | 124 | 10 | 36.29688 | 440 | null | null | 1.599854 | 126 | 7.519531 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 112 | 1 |
72.68195 | male | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 6 | 12 | under $11k | 0 | 2,763 | 2,216.8535 | 1,728.75977 | 10 | white | 21.199219 | 35 | 0.823975 | 0.712891 | 1 | 0 | 0 | no | 0.8 | 0.7 | dnr after sadm | 1 | 62 | 7.799805 | 74 | 32 | 36.09375 | 357.125 | null | 0.599976 | 1.799805 | 131 | 7.399414 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 | 666 | 1 |
71.15094 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 2,546 | 2,086.7031 | 1,616.51953 | 17 | white | 29.796875 | 45 | 0.684937 | 0.517944 | 1 | 0 | 1 | no | 0.8 | 0.5 | no dnr | 4 | 107 | 7.599609 | 96 | 36 | 35.79688 | 370 | 3.399902 | 0.399963 | 3.799805 | 129 | 7.519531 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 | 425 | 1 |
80.98297 | male | 0 | 14 | COPD | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 8,698 | 7,073.2539 | 6,178.77734 | 21 | white | 18.199219 | 32 | 0.803955 | 0.682983 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 98 | 10.798828 | 73 | 40 | 35.79688 | 274.0625 | 4 | 1 | 1.5 | 136 | 7.369141 | null | null | null | 3 | null | null | 2.511099 | 151 | 1 |
70.79297 | male | 0 | 3 | Lung Cancer | Cancer | 1 | 6 | null | 0 | 2,528 | 1,650.9307 | 1,010.27979 | 14 | white | 13.898438 | 16 | 0.75293 | 0.495972 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 3 | 103 | 4.699219 | 101 | 18 | 36.09375 | null | 3.799805 | 0.399963 | 0.899902 | 137 | null | null | null | null | null | null | null | 1.940186 | 386 | 1 |
42.50497 | male | 0 | 7 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 5,223 | 3,816.0859 | 2,861.12891 | 15 | white | 31.199219 | 45 | 0.414978 | 0.112991 | 1 | 1 | 0 | metastatic | null | null | dnr after sadm | 1 | 107 | 24.398438 | 140 | 28 | 36.09375 | 214.28125 | 3 | 0.599976 | 0.899902 | 135 | 7.489258 | null | null | null | 2 | 3 | <2 mo. follow-up | 3 | 20 | 1 |
75.06897 | male | 0 | 3 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 1,650 | 1,356.8184 | 1,012.84961 | 19 | white | 20.898438 | 33 | 0.81897 | 0.704956 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 107 | 9.298828 | 60 | 24 | 35.69531 | 304.75 | 3.899902 | 1.099854 | 2.699707 | 141 | 7.479492 | null | null | null | null | null | null | 2.020996 | 1,641 | 0 |
66.30298 | female | 1 | 68 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 13 | under $11k | 100 | 211,130 | 158,519.25 | 138,657.875 | 31.25 | white | 22 | 32 | 0.32196 | 0.207977 | 30 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 68 | 67 | 12.298828 | 104 | 10 | 38.29688 | 310 | null | null | 2.399902 | 139 | 7.399414 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 | 68 | 1 |
64.91394 | male | 0 | 6 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 3,954 | 3,177.4356 | 3,081.94922 | 10 | white | 17.097656 | 40 | 0.890991 | 0.817993 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 2 | 119 | 13.398438 | 69 | 30 | 37.89844 | 155.53125 | 4.099609 | 0.299988 | 1.5 | 139 | 7.329102 | null | null | null | null | 1 | null | 1 | 1,312 | 1 |
76.06598 | female | 0 | 25 | Coma | Coma | 0 | 8 | null | 61 | 23,227 | 17,351.5156 | 15,446.7266 | 21.25 | white | 23.296875 | 41 | 0.312988 | 0.240997 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 1 | 114 | 12.298828 | 75 | 32 | 39.09375 | 151.40625 | 4.599609 | 0.5 | 0.799927 | 131 | 7.339844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 1,639 | 0 |
84.50098 | male | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | null | 0 | 3,319 | 2,655.6875 | 2,375.48828 | 4 | white | 14.798828 | 23 | 0.860962 | 0.769897 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 105 | 13.099609 | 69 | 20 | 36.19531 | 344.4375 | 3.699707 | 0.199982 | 0.899902 | 141 | 7.479492 | null | null | null | 1 | null | null | 1.1669 | 833 | 1 |
62.35498 | male | 0 | 27 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 57,132 | 47,951.4062 | 49,411.9062 | 28.75 | white | 32.195313 | 40 | 0.678955 | 0.508911 | 2 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 20 | 52 | 6.399414 | 148 | 31 | 36.39844 | 210 | null | null | 0.599976 | 130 | 7.369141 | null | null | null | null | 2 | <2 mo. follow-up | 2 | 41 | 1 |
71.07196 | male | 0 | 41 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 54,979 | 41,784.8125 | 35,870.5625 | 34.25 | white | 28.097656 | 51 | 0.652954 | 0.553955 | 1 | 1 | 0 | yes | 0.25 | 0.015625 | no dnr | 41 | 57 | 15.699219 | 102 | 12 | 38.09375 | 178 | 2.5 | 1.799805 | 2.699707 | 139 | 7.339844 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 | 1,631 | 0 |
50.51599 | female | 0 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 5,910 | 4,305.207 | 3,984.17969 | 20 | white | 20.398438 | 31 | 0.885986 | 0.845947 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 74 | 19.699219 | 110 | 24 | 36.59375 | 261.875 | 3.299805 | 0.5 | 1.399902 | 139 | 7.429688 | null | null | null | 5 | 4 | adl>=4 (>=5 if sur) | 4 | 1,633 | 0 |
79.99695 | male | 0 | 30 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 17 | null | 0 | 65,864 | 41,325.25 | 66,365 | 38.75 | white | 27 | 24 | 0.659912 | 0.56189 | 3 | 0 | 0 | no | 0.35 | 0.35 | dnr after sadm | 18 | 140 | 12.199219 | 138 | 15 | 38.59375 | 224.4375 | null | null | 0.799927 | 125 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 32 | 1 |
56.99399 | male | 1 | 24 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 2,625 | 34,046.4062 | 32,203.25 | 24.333328 | white | 16.898438 | 20 | 0.727905 | 0.455994 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 7 | 51 | 5.199219 | 74 | 24 | 36.69531 | null | 3.699707 | 0.299988 | 0.899902 | 136 | null | null | null | null | null | 4 | <2 mo. follow-up | 4 | 24 | 1 |
70.09399 | male | 0 | 8 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 6,099 | 5,066.2188 | 4,108.25781 | 11.5 | white | 11.199219 | 26 | 0.921997 | 0.866943 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 8 | 80 | 10.798828 | 77 | 20 | 36.39844 | 309.5 | 4.399414 | 0.399963 | 1.599854 | 139 | 7.439453 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 | 1,388 | 1 |
84.30396 | male | 0 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 9 | 29,884 | 21,718.8906 | 18,873.1875 | 20 | white | 27.699219 | 36 | 0.566895 | 0.454956 | 4 | 0 | 1 | no | 0.2 | 0.1 | dnr after sadm | 4 | 78 | 5.899414 | 71 | 15 | 36.5 | 93.32812 | null | null | 2 | 138 | 7.379883 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 29 | 1 |
79.69897 | male | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 9,814 | 8,019.625 | 7,759.37891 | 11 | white | 19.898438 | 34 | 0.735962 | 0.585938 | 1 | 0 | 0 | yes | 0.7 | 0.5 | dnr after sadm | 1 | 110 | 21.199219 | 118 | 28 | 35.59375 | 304.75 | 4.199219 | 0.399963 | 1.199951 | 139 | 7.459961 | null | null | null | null | null | null | 4.431641 | 71 | 1 |
51.27197 | female | 0 | 5 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 2,531 | 2,096.4453 | 1,889.21973 | 6 | white | 11.199219 | 11 | 0.897949 | 0.764893 | 1 | 0 | 0 | metastatic | 0.6 | 0.2 | no dnr | 5 | 75 | null | 89 | 22 | 36.19531 | null | 3.899902 | 0.299988 | 0.799927 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 338 | 1 |
64.62695 | female | 0 | 8 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 5,192 | 4,223.6055 | 3,330.64844 | 13 | white | 16.097656 | 28 | 0.900879 | 0.833984 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 8 | 63 | 11.699219 | 73 | 32 | 36.39844 | 200 | 4.199219 | 0.5 | 0.699951 | 134 | 7.299805 | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 | 1,531 | 1 |
70.21796 | female | 0 | 8 | Coma | Coma | 2 | 8 | under $11k | 44 | 9,225 | 7,920.3242 | 8,289.5625 | 13.5 | white | 17.398438 | 17 | 0.619995 | 0.557983 | 1 | 0 | 1 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 115 | 6.399414 | 60 | 24 | 35.59375 | null | 3.399902 | 0.299988 | 0.899902 | 143 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 | 18 | 1 |
76.22699 | male | 1 | 5 | COPD | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 9 | 7,085 | 4,792.3516 | 4,949.99609 | 26 | white | 17.5 | 23 | 0.819946 | 0.706909 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 5 | 85 | 13.599609 | 138 | 10 | 38.09375 | 170 | 4.299805 | 0.299988 | 1.199951 | 139 | 7.399414 | null | null | null | null | 4 | <2 mo. follow-up | 4 | 5 | 1 |
76.159 | male | 0 | 4 | Lung Cancer | Cancer | 2 | 8 | $11-$25k | 0 | 3,508 | 2,545.4492 | 2,052.04883 | 11 | white | 19 | 25 | 0.636963 | 0.327942 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 67 | 18.597656 | 66 | 24 | 36.29688 | null | null | null | 1 | 132 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 | 257 | 1 |
64.71698 | male | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | >$50k | 0 | 2,744 | 2,202.8066 | 1,636.71973 | 18 | white | 26.199219 | 33 | 0.782959 | 0.651978 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 67 | 10 | 57 | 24 | 36.09375 | null | 3.599609 | 1.799805 | 2.399902 | 129 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 | 38 | 1 |
83.474 | male | 0 | 8 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 4,876 | 4,143.4727 | 3,467.36914 | 7 | white | 18.097656 | 20 | 0.78894 | 0.661987 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 8 | 106 | 10 | 69 | 24 | 35.39844 | null | null | null | 1.299805 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,622 | 0 |
44.34799 | female | 0 | 7 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 58,947 | 62,907.3125 | 65,362.875 | 20 | white | 23.796875 | 18 | 0.755981 | 0.5 | 1 | 0 | 0 | metastatic | 0.49 | 0.39 | dnr after sadm | 6 | 101 | 5.5 | 132 | 20 | 38.19531 | null | null | null | 0.599976 | 128 | null | null | null | null | 1 | 0 | adl>=4 (>=5 if sur) | 0 | 118 | 1 |
57.36099 | male | 1 | 6 | Coma | Coma | 2 | null | null | 44 | 5,527 | 4,044.2441 | 4,410.9375 | 23 | white | 18.296875 | 19 | 0.634888 | 0.573975 | 1 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 1 | 72 | 11.099609 | 101 | 24 | 38 | null | null | null | 1.399902 | 148 | null | null | null | null | null | null | <2 mo. follow-up | 2.000488 | 6 | 1 |
78.89899 | female | 0 | 9 | Colon Cancer | Cancer | 1 | null | null | 0 | 13,276 | 8,470.8203 | 4,400.08984 | 16.5 | white | 13.699219 | 18 | 0.834961 | 0.639893 | 1 | 0 | 0 | metastatic | 0.7 | 0.6 | no dnr | 9 | 68 | 7.299805 | 67 | 16 | 36.79688 | null | 3.599609 | 0.399963 | 0.699951 | 141 | null | null | null | null | null | null | null | 2.405762 | 807 | 1 |
60.76099 | male | 0 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 20 | null | 26 | 10,343 | 8,276 | 6,551.45703 | 12.5 | white | 25.699219 | 44 | 0.718994 | 0.632935 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 9 | 122 | 12.798828 | 108 | 28 | 36.29688 | 525.875 | 2.5 | 0.899902 | 11.5 | 132 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 176 | 1 |
58.54099 | male | 0 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 43,636 | 37,861.7188 | 31,906.5312 | 17.333328 | white | 19.296875 | 34 | 0.777954 | 0.705933 | 11 | 0 | 0 | yes | null | null | no dnr | 23 | 103 | 34.398438 | 98 | 24 | 37.89844 | 219.96875 | null | null | 1.5 | 145 | 7.419922 | null | null | null | null | null | null | 1.980469 | 1,618 | 0 |
67.39996 | male | 1 | 7 | COPD | COPD/CHF/Cirrhosis | 6 | 20 | under $11k | 0 | 6,910 | 4,843.6016 | 4,028.19922 | 13.5 | white | 41.59375 | 46 | 0.311951 | 0.130981 | 1 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 2 | 115 | 35.296875 | 114 | 32 | 36.09375 | 69.375 | 3.299805 | 0.699951 | 0.5 | 128 | 7.269531 | null | null | null | null | 3 | <2 mo. follow-up | 3 | 7 | 1 |
65.57397 | female | 1 | 8 | Coma | Coma | 4 | 12 | under $11k | 100 | 16,053 | 11,305.8203 | 11,408.7734 | 26.5 | white | 28.796875 | 28 | 0.046997 | 0.023998 | 8 | 1 | 1 | no | 0.1 | 0.001 | no dnr | 8 | 44 | 12.199219 | 78 | 8 | 38 | 170 | 2.699707 | 0.299988 | 0.899902 | 131 | 7.449219 | null | null | null | null | 4 | <2 mo. follow-up | 4 | 8 | 1 |
79.10199 | female | 0 | 24 | Colon Cancer | Cancer | 1 | 8 | under $11k | 0 | 12,781 | 11,217.625 | 9,313.01562 | 12.333328 | white | 17.097656 | 33 | 0.78894 | 0.554932 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 107 | 8.798828 | 84 | 28 | 36.59375 | 342.8125 | 3.399902 | 0.599976 | 1.199951 | 134 | 7.469727 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 37 | 1 |
68.383 | male | 0 | 9 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | $11-$25k | 0 | 5,863 | 4,946.7148 | 4,396.44922 | 6 | white | 24.699219 | 47 | 0.789917 | 0.66394 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 1 | 53 | 13 | 70 | 24 | 36.79688 | 214.8125 | 4 | 0.799927 | 2.299805 | 130 | 7.419922 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 | 64 | 1 |
78.95697 | female | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 4,206 | 3,423.6699 | 2,941.35938 | 15 | white | 20.699219 | 31 | 0.805908 | 0.68689 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 5 | 54 | 5.599609 | 59 | 24 | 36.89844 | null | 3.299805 | 1 | 1.299805 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,610 | 0 |
73.04596 | female | 0 | 21 | Colon Cancer | Cancer | 1 | 14 | under $11k | 37 | 10,583 | 9,048.7578 | 8,211.65625 | 7.333332 | white | 11.798828 | 17 | 0.781982 | 0.542969 | 1 | 0 | 0 | metastatic | 1 | 0.55 | dnr after sadm | 15 | 129 | 4.5 | 93 | 16 | 37.89844 | null | 3.799805 | 1.699951 | 1 | 134 | null | null | null | null | null | 1 | no(M2 and SIP pres) | 1 | 77 | 1 |
40.39697 | male | 1 | 23 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 82,155 | 101,362.375 | 95,366.9375 | 38.333313 | white | 34 | 68 | 0.35199 | 0.234985 | 53 | 0 | 0 | yes | 0.05 | 0.000125 | no dnr | 23 | 64 | 0.099991 | 146 | 34 | 40.09375 | null | 2.899902 | 2.5 | 1.199951 | 133 | null | null | null | null | null | 1 | <2 mo. follow-up | 1 | 23 | 1 |
42.133 | female | 1 | 75 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 26 | 262,140 | 178,584.375 | 151,271.625 | 42.5 | white | 30 | 31 | 0.652954 | 0.553955 | 9 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 74 | 103 | 15.5 | 120 | 12 | 39.69531 | 103.32812 | 2.399902 | 0.5 | 0.599976 | 137 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 75 | 1 |
74.95697 | male | 0 | 4 | Lung Cancer | Cancer | 1 | 15 | $25-$50k | 9 | 3,143 | 2,138.3906 | 1,401.7793 | 10 | white | 13.099609 | 20 | 0.72998 | 0.457947 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 4 | 119 | 14.599609 | 87 | 20 | 36.09375 | null | 3.799805 | 0.299988 | 1.199951 | 138 | null | null | null | null | null | null | <2 mo. follow-up | 2.061523 | 52 | 1 |
73.04297 | female | 0 | 10 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 8,504 | 6,603.0742 | 5,872.08984 | 17 | white | 17.796875 | 27 | 0.851929 | 0.755981 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 107 | 19.296875 | 65 | 28 | 36 | 216 | 3.799805 | 0.599976 | 1.099854 | 138 | 7.389648 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 | 1,164 | 1 |
80.78894 | male | 0 | 6 | COPD | COPD/CHF/Cirrhosis | 4 | 7 | under $11k | 0 | 3,369 | 2,766.6016 | 2,815.76953 | 14 | white | 21.699219 | 34 | 0.691895 | 0.526978 | 1 | 0 | 0 | yes | 0.5 | 0.1 | no dnr | 6 | 70 | 7 | 114 | 28 | 35.69531 | 460 | null | 0.799927 | 1.199951 | 138 | 7.339844 | null | null | null | null | null | null | 3.179199 | 644 | 1 |
78.02295 | female | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 5,563 | 4,325.4375 | 3,838.91992 | 9 | white | 14.798828 | 38 | 0.825928 | 0.716919 | 1 | 1 | 0 | yes | null | null | no dnr | 7 | 109 | 6.199219 | 76 | 28 | 36.79688 | 204.75 | 3 | 0.199982 | 0.599976 | 140 | 7.369141 | null | null | null | 2 | 4 | no(M2 and SIP pres) | 4 | 1,604 | 0 |
74.25598 | female | 0 | 16 | Colon Cancer | Cancer | 1 | 8 | $11-$25k | 0 | 7,361 | 6,515.6016 | 6,316.35938 | 7.666664 | white | 6.5 | 20 | 0.908936 | 0.789917 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 16 | 104 | 7.299805 | 74 | 24 | 38 | null | 4 | 0.5 | 1.099854 | 136 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 111 | 1 |
71.02295 | female | 0 | 4 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 1,851 | 1,514.1279 | 1,188 | 11 | white | 18.5 | 22 | 0.853882 | 0.758911 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 4 | 107 | null | 98 | 28 | 36 | 452 | null | null | null | 140 | 7.379883 | null | null | null | null | null | null | 2.083496 | 170 | 1 |
68.44897 | male | 0 | 7 | Colon Cancer | Cancer | 1 | null | null | 0 | 3,947 | 3,385.7012 | 3,018.31836 | 6 | white | 16.296875 | 14 | 0.819946 | 0.611938 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 80 | 10 | 107 | 24 | 38.59375 | null | 3.599609 | 0.5 | 1 | 133 | null | null | null | null | null | null | null | 2.251465 | 70 | 1 |
64.698 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 1,917 | 1,679.8438 | 1,222.37988 | 14 | white | 16.796875 | 16 | 0.892944 | 0.819946 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 70 | null | 73 | 16 | 35.39844 | null | null | null | 1.199951 | 140 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.821289 | 1,600 | 0 |
82.99799 | male | 1 | 4 | CHF | COPD/CHF/Cirrhosis | 7 | null | null | 0 | 2,277 | 1,776.459 | 1,493.75977 | 26 | white | 20.398438 | 39 | 0.746948 | 0.601929 | 1 | 1 | 1 | yes | 0.1 | 0.001 | dnr after sadm | 1 | 106 | 9.298828 | 60 | 40 | 37.89844 | 300 | 3.199707 | 0.899902 | 1.5 | 145 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 6.266602 | 4 | 1 |
54.79498 | female | 0 | 11 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 10,684 | 7,769.9062 | 7,832.01953 | 19.5 | white | 18.398438 | 22 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 11 | 110 | 12.099609 | 76 | 32 | 36.79688 | 193.3125 | null | null | 0.899902 | 140 | 7.379883 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 1,598 | 0 |
75.09399 | male | 0 | 10 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 9 | 15,305 | 10,673.5938 | 8,756.25 | 33 | white | 24.699219 | 41 | 0.455994 | 0.253967 | 1 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 1 | 117 | 12.199219 | 42 | 49 | 36.29688 | null | 3 | 2.699707 | 1.199951 | 136 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 60 | 1 |
57.88098 | female | 0 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 66,800 | 45,979.0625 | 47,007.7188 | 37 | white | 36.398438 | 60 | 0.600952 | 0.493958 | 1 | 0 | 0 | no | null | null | no dnr | 39 | 49 | 7.599609 | 138 | 39 | 39.39844 | 195 | 2.899902 | 4.899414 | 1.599854 | 148 | 7.389648 | null | null | null | null | 1 | null | 1 | 1,596 | 0 |
72.56097 | male | 0 | 7 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 3,628 | 3,037.8301 | 2,097.91992 | 6 | white | 26.097656 | 53 | 0.748901 | 0.603882 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 1 | 53 | 7.899414 | 74 | 28 | 34.69531 | 545.625 | 4 | 2.899902 | 1.899902 | 139 | 7.339844 | null | null | null | null | 5 | <2 mo. follow-up | 5 | 49 | 1 |
70.26398 | female | 0 | 9 | Colon Cancer | Cancer | 2 | 8 | null | 0 | 12,682 | 10,659.3516 | 11,444.0547 | 13.5 | white | 17 | 14 | 0.807983 | 0.588989 | 1 | 0 | 0 | metastatic | 0.75 | 0.25 | no dnr | 9 | 60 | 12.898438 | 77 | 20 | 38.69531 | null | 3.299805 | 0.199982 | 0.799927 | 134 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 | 22 | 1 |
70.66095 | female | 0 | 15 | MOSF w/Malig | ARF/MOSF | 1 | 16 | null | 9 | 15,128 | 11,270.9531 | 10,102.7734 | 16.666656 | white | 25.597656 | 36 | 0.497986 | 0.380981 | 3 | 0 | 0 | metastatic | null | null | no dnr | 15 | 142 | 5.899414 | 138 | 16 | 36 | 452 | 3.899902 | 0.5 | 1.899902 | 142 | 7.369141 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 | 1,269 | 1 |
74.97595 | male | 0 | 22 | Coma | Coma | 0 | 14 | >$50k | 0 | 44,963 | 32,121.5469 | 28,611.6094 | 31.666656 | white | 18.199219 | 15 | 0.73291 | 0.68396 | 1 | 0 | 0 | no | 0.99 | 0.9 | no dnr | 22 | 117 | 7.199219 | 66 | 24 | 36.79688 | 163 | 4.399414 | 0.599976 | 0.899902 | 138 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,590 | 0 |
61.61499 | female | 0 | 3 | Lung Cancer | Cancer | 1 | 13 | null | 0 | 2,784 | 2,036.6143 | 1,695.25977 | 3 | white | 15.798828 | 10 | 0.738892 | 0.471985 | 1 | 0 | 0 | metastatic | 0.95 | 0.6 | no dnr | 3 | 100 | null | 93 | 20 | 36.19531 | null | null | null | null | 140 | null | null | null | null | null | null | <2 mo. follow-up | 1.985352 | 5 | 1 |
66.97894 | male | 0 | 5 | Lung Cancer | Cancer | 2 | 15 | under $11k | 0 | 3,928 | 3,099.3711 | 2,706.92969 | 7 | white | 8.699219 | 19 | 0.835938 | 0.640991 | 1 | 1 | 0 | metastatic | 0.8 | 0.6 | no dnr | 5 | 111 | 8 | 72 | 20 | 35.19531 | null | 4.299805 | 0.599976 | 1.099854 | 134 | null | null | null | null | null | 1 | no(M2 and SIP pres) | 1 | 528 | 1 |
53.91599 | female | 0 | 17 | Coma | Coma | 1 | 11 | $11-$25k | 0 | 24,481 | 16,262.6328 | 22,232.1719 | 22.333328 | white | 19 | 12 | 0.767944 | 0.723999 | 3 | 0 | 0 | yes | 0.8 | 0.8 | dnr after sadm | 1 | 119 | 16.296875 | 42 | 10 | 38.39844 | 262.5 | 4.199219 | 0.599976 | 0.799927 | 143 | 7.489258 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 1,588 | 0 |
47.07498 | female | 0 | 57 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 44 | 82,385 | 56,124.2812 | 56,664.5938 | 32 | white | 25.398438 | 24 | 0.691895 | 0.526978 | 1 | 0 | 0 | metastatic | 0.3 | 0.3 | no dnr | 57 | 75 | 12.699219 | 127 | 8 | 38.79688 | 116 | 3.599609 | 0.399963 | 0.899902 | 141 | 7.169922 | null | null | null | null | null | null | 4.09668 | 119 | 1 |
89.54095 | female | 1 | 4 | Coma | Coma | 0 | 14 | null | 100 | 4,136 | 3,253.3594 | 2,923.5293 | 22 | white | 31.699219 | 67 | 0.003 | 0.001 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 58 | 9.099609 | 110 | 40 | 38.5 | 140.8125 | 4.5 | 0.799927 | 3 | 143 | 7.169922 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 4 | 1 |
91.34595 | male | 1 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 20,829 | 13,574.1875 | 13,898.7656 | 41 | white | 40.398438 | 57 | 0.213989 | 0.117996 | 3 | 0 | 1 | no | 0.3 | 0.3 | dnr after sadm | 7 | 47 | 15.599609 | 160 | 9 | 39.69531 | 123.32812 | 2.599609 | 1.399902 | 1.699951 | 133 | 7.429688 | null | null | null | null | 2 | <2 mo. follow-up | 2 | 7 | 1 |
88.79895 | male | 1 | 5 | Coma | Coma | 1 | 6 | under $11k | 100 | 2,583 | 2,126.9863 | 1,623.67969 | 12 | white | 19.796875 | 40 | 0.112 | 0.067993 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 61 | 8.199219 | 66 | 10 | 38.79688 | 352.375 | 4.099609 | 1.699951 | 2 | 138 | 7.429688 | null | null | null | null | 3 | <2 mo. follow-up | 3 | 5 | 1 |
78.02295 | female | 1 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | $11-$25k | 0 | 33,443 | 21,901.5781 | 21,580.6875 | 31 | white | 34.09375 | 48 | 0.340942 | 0.224976 | 12 | 0 | 0 | yes | 0.25 | 0.25 | no dnr | 10 | 107 | 0.399963 | 120 | 26 | 36.39844 | 268 | null | null | 0.599976 | 131 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 10 | 1 |
82.31299 | male | 0 | 3 | Coma | Coma | 0 | 8 | under $11k | 100 | 6,698 | 4,614.625 | 4,624.59766 | 57 | white | 47 | 51 | 0 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 42 | 15.099609 | 114 | 20 | 35.89844 | 12 | 3 | 0.599976 | 1.399902 | 145 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 4 | 1 |
63.12097 | male | 0 | 5 | Lung Cancer | Cancer | 2 | null | null | 0 | 4,309 | 3,033.959 | 3,010.70898 | 11 | white | 11 | 16 | 0.81189 | 0.596924 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 5 | 103 | 5.5 | 104 | 22 | 36.29688 | null | 4.199219 | 0.699951 | 0.799927 | 134 | null | null | null | null | null | null | null | 1.967285 | 89 | 1 |
75.88995 | male | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 26 | 4,709 | 3,727.0742 | 3,350.64844 | 11 | white | 24.699219 | 47 | 0.636963 | 0.454956 | 1 | 1 | 1 | no | 0.8 | 0.7 | dnr after sadm | 1 | 69 | 11.599609 | 104 | 24 | 35.5 | 157.125 | 3.899902 | 0.599976 | 1.599854 | 135 | 7.369141 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 | 58 | 1 |
75.87695 | male | 0 | 7 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | $25-$50k | 0 | 4,041 | 3,294.3086 | 2,848.53906 | 17 | white | 15 | 35 | 0.881958 | 0.802979 | 1 | 0 | 0 | no | 0.8 | 0.7 | dnr after sadm | 1 | 63 | 9.898438 | 73 | 28 | 35.79688 | 295.1875 | 3.899902 | 0.799927 | 1.099854 | 140 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 977 | 1 |
64.45996 | female | 0 | 12 | COPD | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 10,293 | 7,336.9844 | 7,129.15625 | 11.5 | white | 19.398438 | 20 | 0.840942 | 0.738892 | 1 | 0 | 0 | yes | 0.75 | 0.75 | no dnr | 12 | 87 | 34.398438 | 132 | 24 | 38.29688 | 285.125 | 4.099609 | 0.799927 | 0.699951 | 134 | 7.419922 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 | 1,179 | 1 |
60.42999 | female | 0 | 5 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,457 | 2,783.0488 | 2,312.45898 | 15 | white | 7.599609 | 11 | 0.85791 | 0.68396 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 72 | 3.5 | 70 | 20 | 36.19531 | null | 4.199219 | 0.399963 | 0.799927 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.710938 | 1,513 | 1 |
67.16498 | male | 0 | 8 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 5,430 | 4,154.957 | 3,476.1582 | 8 | white | 24.097656 | 36 | 0.757935 | 0.615967 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 8 | 101 | 21 | 120 | 24 | 35.69531 | 209.0625 | null | null | 1.099854 | 138 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 898 | 1 |
52.95798 | male | 0 | 5 | Lung Cancer | Cancer | 2 | 9 | under $11k | 0 | 2,227 | 1,943.7852 | 1,477.59961 | 10 | white | 14.798828 | 16 | 0.773926 | 0.529907 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 5 | 107 | 7.799805 | 77 | 24 | 36.79688 | null | null | null | 1.399902 | 136 | null | null | null | null | null | 1 | no(M2 and SIP pres) | 1 | 686 | 1 |
82.57898 | female | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 4 | 16 | null | 0 | 2,881 | 2,437.209 | 1,677.16992 | 10 | white | 20.398438 | 23 | 0.748901 | 0.60498 | 1 | 1 | 0 | yes | 1 | 1 | no dnr | 6 | 106 | 10.599609 | 54 | 24 | 35.59375 | 342.8125 | null | null | 1.199951 | 135 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,572 | 0 |
54.883 | male | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 15,018 | 10,734.4688 | 10,703.6641 | 19 | white | 22.898438 | 40 | 0.859985 | 0.768921 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 58 | 8.699219 | 50 | 22 | 36.39844 | null | 4.099609 | 0.599976 | 2.599609 | 130 | null | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 | 296 | 1 |
70.57098 | male | 0 | 6 | Lung Cancer | Cancer | 2 | 7 | under $11k | 0 | 3,154 | 2,479.1641 | 2,328.84961 | 6 | white | 3.099609 | 23 | 0.888916 | 0.746948 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 6 | 69 | 6 | 81 | 24 | 36.59375 | null | 4.399414 | 0.399963 | 1.099854 | 142 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.677246 | 254 | 1 |
82.06696 | male | 0 | 6 | Lung Cancer | Cancer | 2 | 8 | null | 0 | 3,685 | 3,021.3086 | 2,684.58984 | 8 | white | 14.099609 | 26 | 0.725952 | 0.451965 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 6 | 77 | 6.099609 | 77 | 22 | 35.59375 | null | 3.699707 | 0.399963 | 1.099854 | 134 | null | null | null | null | 0 | null | null | 0.4948 | 356 | 1 |
68.17798 | male | 0 | 6 | Colon Cancer | Cancer | 3 | 12 | $25-$50k | 0 | 3,745 | 2,759.084 | 2,308.72852 | 10 | white | 18.199219 | 13 | 0.793945 | 0.564941 | 1 | 1 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 92 | null | 56 | 20 | 35.59375 | null | null | null | null | 140 | null | null | null | null | 0 | 1 | null | 1 | 101 | 1 |
84.03796 | female | 0 | 8 | COPD | COPD/CHF/Cirrhosis | 5 | 12 | null | 0 | 5,013 | 3,908.5117 | 3,510.07812 | 14.5 | white | 15.5 | 41 | 0.822998 | 0.711914 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 1 | 59 | 11.898438 | 69 | 26 | 36.19531 | 268 | 3.899902 | 0.299988 | 1 | 137 | 7.379883 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 | 1,566 | 0 |
66.31299 | male | 0 | 7 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 14,233 | 11,140.5781 | 9,157.45312 | 13 | white | 21.199219 | 19 | 0.800903 | 0.678955 | 9 | 0 | 0 | no | null | null | no dnr | 7 | 62 | null | 105 | 20 | 38 | 145 | null | null | 1.199951 | 135 | 7.429688 | null | null | null | 0 | 3 | no(M2 and SIP pres) | 3 | 1,566 | 0 |
58.883 | male | 1 | 4 | Coma | Coma | 0 | 6 | $11-$25k | 100 | 10,109 | 6,643.3828 | 7,060.84766 | 27 | white | 27.097656 | 45 | 0.182983 | 0.125977 | 1 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 1 | 167 | 15.599609 | 182 | 8 | 39 | 164 | 4.599609 | 0.399963 | 0.799927 | 155 | 7.569336 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 4 | 1 |
81.88397 | female | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 2 | 6 | null | 0 | 2,367 | 1,813.1553 | 1,324.67969 | 6 | hispanic | 16.699219 | 35 | 0.846924 | 0.748901 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 4 | 61 | 4.599609 | 80 | 28 | 36 | 252.375 | null | null | 1.099854 | 136 | 7.519531 | null | null | null | null | null | no(M2 and SIP pres) | 2.143066 | 1,045 | 1 |
70.034 | male | 0 | 32 | Coma | Coma | 0 | 16 | >$50k | 44 | 36,490 | 25,928.2812 | 25,123.3438 | 18.5 | white | 23 | 18 | 0.471985 | 0.399963 | 1 | 0 | 0 | no | null | null | no dnr | 32 | 133 | 18.796875 | 106 | 10 | 38.09375 | 140 | null | null | 1 | 143 | 7.529297 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 1,566 | 0 |
45.06497 | female | 0 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 9,426 | 7,679.543 | 6,140.44922 | 9 | white | 17.898438 | 17 | 0.922974 | 0.868896 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 74 | 10.5 | 126 | 20 | 35.59375 | null | 4.299805 | 1.299805 | 1.099854 | 139 | null | null | null | null | 0 | null | null | 0.4948 | 1,564 | 0 |
81.85394 | male | 0 | 13 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | $11-$25k | 0 | 6,725 | 5,676.6602 | 4,296.05859 | 7.5 | white | 17.398438 | 32 | 0.838989 | 0.736938 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 13 | 112 | 7.899414 | 76 | 20 | 36.19531 | 238.09375 | 3.699707 | 0.799927 | 1.799805 | 133 | 7.509766 | null | null | null | 5 | 5 | SIP>=30 | 5 | 1,083 | 1 |
61.71399 | female | 0 | 41 | Coma | Coma | 0 | 12 | null | 61 | 57,452 | 48,214.875 | 45,286.1875 | 30.25 | white | 16.796875 | 21 | 0.632935 | 0.571899 | 1 | 0 | 0 | no | 1 | 0.99 | no dnr | 41 | 123 | 19.296875 | 68 | 8 | 38 | 210 | 4.799805 | 0.899902 | 1.099854 | 147 | 7.439453 | null | null | null | null | 0 | null | 0 | 65 | 1 |
71.461 | female | 0 | 42 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | null | 0 | 43,218 | 32,969 | 26,999.2969 | 18.75 | white | 33.59375 | 59 | 0.509888 | 0.392944 | 1 | 1 | 0 | yes | 0.8 | 0.8 | no dnr | 42 | 68 | 28 | 134 | 28 | 35.19531 | null | 3.199707 | 0.5 | 5.899414 | 132 | null | null | null | null | null | 5 | no(M2 and SIP pres) | 5 | 1,562 | 0 |
80.84094 | female | 0 | 13 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 17,250 | 12,146.3047 | 10,440.8125 | 19.5 | white | 16.597656 | 23 | 0.851929 | 0.755981 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 13 | 63 | 6 | 52 | 20 | 36.69531 | null | null | null | 1.199951 | 141 | null | null | null | null | null | null | null | 3.058594 | 1,563 | 0 |
71.58099 | male | 0 | 3 | Lung Cancer | Cancer | 1 | 9 | $11-$25k | 0 | 1,985 | 1,450.2559 | 1,251.7793 | 7 | white | 16 | 20 | 0.711914 | 0.430969 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 3 | 117 | 5.5 | 62 | 24 | 36.09375 | null | 3.599609 | 0.5 | 1.5 | 139 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.019043 | 1,560 | 0 |
59.49298 | male | 0 | 5 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 2,963 | 2,366.2129 | 1,990.06934 | 9 | white | 24.898438 | 19 | 0.53894 | 0.215973 | 1 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 1 | 73 | 40 | 101 | 20 | 36 | 338.0625 | null | 0.599976 | 0.799927 | 130 | 7.40918 | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 | 59 | 1 |
74.55695 | male | 0 | 3 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | null | 0 | 2,100 | 1,671.5469 | 1,479.7793 | 18 | white | 9.898438 | 26 | 0.914917 | 0.855957 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 3 | 71 | 9.298828 | 60 | 20 | 36.19531 | 376.1875 | 4.799805 | 0.5 | 1.299805 | 141 | 7.459961 | null | null | null | null | null | null | 2.165039 | 1,560 | 0 |
70.11096 | male | 1 | 10 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 10,505 | 7,555.5586 | 6,805.32812 | 26.5 | white | 19.398438 | 45 | 0.8479 | 0.75 | 1 | 0 | 0 | no | 0.9 | 0.75 | dnr after sadm | 9 | 105 | 36.398438 | 110 | 36 | 38.29688 | 242.84375 | 4 | 0.399963 | 1.399902 | 136 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.825684 | 10 | 1 |
58.71899 | male | 0 | 343 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $25-$50k | 0 | 556,878 | 463,230 | 409,602 | 47.75 | white | 45.695313 | 66 | 0.221985 | 0.123993 | 13 | 0 | 0 | no | null | null | dnr after sadm | 45 | 53 | 20.699219 | 124 | 34 | 39.19531 | 62.10156 | null | null | 4.399414 | 153 | 7.25 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 | 1,558 | 0 |
63.16498 | female | 0 | 6 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 2,532 | 2,167.4883 | 1,894.41992 | 9 | white | 19.5 | 21 | 0.660889 | 0.358948 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 6 | 73 | 2 | 107 | 16 | 37.89844 | null | null | null | 1 | 129 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.09668 | 556 | 1 |
79.77496 | male | 0 | 5 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 3,239 | 2,465.4785 | 2,160.48828 | 16 | white | 16.296875 | 27 | 0.835938 | 0.731934 | 1 | 0 | 0 | no | 0.99 | 0.8 | no dnr | 5 | 93 | 7.399414 | 71 | 22 | 36.09375 | 190.46875 | 3.599609 | 0.299988 | 1.199951 | 137 | 7.439453 | null | null | null | null | null | null | 2.457031 | 1,555 | 0 |
63.48297 | male | 0 | 116 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 37 | 101,761 | 154,723.125 | 129,909.062 | 27.5 | white | 36 | 47 | 0.287964 | 0.177979 | 10 | 1 | 0 | no | 0.8 | 0.9 | no dnr | 116 | 100 | 15.199219 | 116 | 12 | 39.69531 | 212.5 | 3.399902 | 7.699219 | 4.199219 | 150 | 7.399414 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 | 618 | 1 |
88.11499 | male | 0 | 11 | COPD | COPD/CHF/Cirrhosis | 1 | 5 | null | 0 | 7,987 | 6,105.9609 | 4,972.75 | 14 | white | 21.097656 | 36 | 0.702881 | 0.539917 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 105 | 11.298828 | 100 | 36 | 36.19531 | 159.15625 | 4.399414 | 0.399963 | 1.699951 | 142 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 1,347 | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.